Gene · 84649
Papers1,612
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,612
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MASLD treatment-a shift in the paradigm is imminent. | Front Med (Lausanne) | 2023 | 38146424 | PubTator, text mining | PubMed |
| Metformin Inefficiency to Lower Lipids in Vitamin B12 Deficient HepG2 Cells Is Alleviated via Adiponectin-AMPK Axis. | Nutrients | 2023 | 38140305 | PubTator, text mining | PubMed |
| An Overview on Lipid Droplets Accumulation as Novel Target for Acute Myeloid Leukemia Therapy. | Biomedicines | 2023 | 38137407 | PubTator, text mining | PubMed |
| Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis. | Biomedicines | 2023 | 38137330 | PubTator, text mining | PubMed |
| JOINTLY: interpretable joint clustering of single-cell transcriptomes. | Nat Commun | 2023 | 38123569 | PubTator, text mining | PubMed |
| Cellular microenvironment: a key for tuning mesenchymal stem cell senescence. | Front Cell Dev Biol | 2023 | 38111850 | PubTator, text mining | PubMed |
| Lipid compartments and lipid metabolism as therapeutic targets against coronavirus. | Front Immunol | 2023 | 38106410 | PubTator, text mining | PubMed |
| Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell-derived epicardial cells. | Nat Commun | 2023 | 38081833 | PubTator, text mining | PubMed |
| Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer. | Cancers (Basel) | 2023 | 38001668 | PubTator, text mining | PubMed |
| Application of synthetic lipid droplets in metabolic diseases. | Clin Transl Med | 2023 | 37997538 | PubTator, text mining | PubMed |
| Qa-SNARE syntaxin 18 mediates lipid droplet fusion with SNAP23 and SEC22B. | Cell Discov | 2023 | 37989733 | PubTator, text mining | PubMed |
| Inhibition of intestinal FXR activity as a possible mechanism for the beneficial effects of a probiotic mix supplementation on lipid metabolism alterations and weight gain in mice fed a high fat diet. | Gut Microbes | 2023 | 37985749 | PubTator, text mining | PubMed |
| Placental extract suppresses lipid droplet accumulation by autophagy during the differentiation of adipose-derived mesenchymal stromal/stem cells into mature adipocytes. | BMC Res Notes | 2023 | 37974253 | PubTator, text mining | PubMed |
| Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms. | J Exp Clin Cancer Res | 2023 | 37951921 | PubTator, text mining | PubMed |
| Microbiota in cancer: molecular mechanisms and therapeutic interventions. | MedComm (2020) | 2023 | 37937304 | PubTator, text mining | PubMed |
| Inflammation and altered metabolism impede efficacy of functional electrical stimulation in critically ill patients. | Crit Care | 2023 | 37932834 | PubTator, text mining | PubMed |
| Association between dietary intakes of B vitamins and nonalcoholic fatty liver disease in postmenopausal women: a cross-sectional study. | Front Nutr | 2023 | 37927496 | PubTator, text mining | PubMed |
| Case report: Diagnosis and treatment of DGAT1 deficiency-induced congenital diarrhea in two cases and literature review. | Front Pediatr | 2023 | 37908965 | PubTator, text mining | PubMed |
| Extracellular matrix modulates the spatial hepatic features in hepatocyte-like cells derived from human embryonic stem cells. | Stem Cell Res Ther | 2023 | 37907977 | PubTator, text mining | PubMed |
| Multitargeted Herbal Prescription So Shiho Tang: A Scoping Review on Biomarkers for the Evaluation of Therapeutic Effects. | Pharmaceuticals (Basel) | 2023 | 37895842 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84649/papers?page=8